Impact of nickel oral hyposensitization on quality of life in systemic nickel allergy syndrome

Nickel (Ni) oral hyposensitization treatment (NiOHT) is an effective management approach for Ni allergy. No health-related quality of life (HRQoL) data exist for the pre- and post-treatment with NiOHT in systemic nickel allergy syndrome (SNAS). The aims of this study were (a) to explore HRQoL in SNA...

Full description

Saved in:
Bibliographic Details
Published in:International journal of immunopathology and pharmacology 2020, Vol.34, p.2058738420934629-2058738420934629
Main Authors: Rizzi, Angela, Di Rienzo, Alessia, Buonomo, Alessandro, Aruanno, Arianna, Carusi, Valentina, Ricci, Anna Giulia, Centrone, Michele, Mezzacappa, Simona, Romeo, Lilli, Schiavino, Domenico, Inchingolo, Riccardo, Gasbarrini, Antonio, Nucera, Eleonora
Format: Article
Language:English
Subjects:
Adult
Aged
Allergies
Anxiety
Anxiety - etiology
Anxiety - psychology
Cohort Studies
Depression - etiology
Depression - psychology
Desensitization, Immunologic - methods
Female
Food allergies
Humans
Hypersensitivity - psychology
Hypersensitivity - therapy
Hypochondriasis - etiology
Hypochondriasis - psychology
Male
Mental depression
Middle Aged
MMPI
Mood
Nickel
Original
Patch Tests
Precision Medicine
Quality of Life
Surveys and Questionnaires
Syndrome
Treatment Outcome
Well being
Young Adult
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Nickel (Ni) oral hyposensitization treatment (NiOHT) is an effective management approach for Ni allergy. No health-related quality of life (HRQoL) data exist for the pre- and post-treatment with NiOHT in systemic nickel allergy syndrome (SNAS). The aims of this study were (a) to explore HRQoL in SNAS patients, (b) to assess changes of HRQoL after 1 year of NiOHT; (c) to evaluate psychological status of patients. SNAS patients completed the Short-Form 36-Item Health Survey and Psychological General Well-Being Index before and 1 week after the end of NiOHT. Moreover, psychological state was assessed with the Minnesota Multiphasic Personality Inventory (MMPI-2). A total of 52 patients self-reported pre- and post-treatment questionnaires. HRQoL was poor at baseline. After 1 year of NiOHT, all outcome measure scores improved by about 20% with respect to baseline data (P 
ISSN:2058-7384
0394-6320
2058-7384
DOI:10.1177/2058738420934629